New treatment option for young women with hormone-sensitive breast cancer

[News]

The aromatase inhibitor exemestane is more effective than tamoxifen in preventing breast cancer recurrence in young women who also receive ovarian function suppression as adjuvant (post-surgery)...

More... (http://www.medicalnewstoday.com/releases/277649.php)